Investor Alert

Market Pulse Archives

April 13, 2021, 7:25 a.m. EDT

UPDATE: FDA and CDC call for pause in use of J&J vaccine over blood clotting disorder

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    AstraZeneca PLC ADR (AZN)
  • X
    AstraZeneca PLC (AZN)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

The two leading federal public health agencies called for an immediate pause in the use of the Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.15% COVID-19 vaccine on Tuesday, after six recipients in the U.S. developed a rare disorder involving blood clots within six to 13 days after being vaccinated. The news was first reported by the New York Times, citing officials briefed on the decision. The U.S. Food and Drug Administration and Centers for Disease Control and Prevention said all six were women aged between 18 and 48 and emphasized that the adverse events appear to be "extremely rare." "In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia)," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC said in a statement. So far, nearly 7 million Americans have received J&J shots, and about 9 million more have been delivered to states, CDC data shows. Scientists from the FDA and CDC will jointly investigate possible links between the vaccine and the clotting disorder and determine whether it should continue to be used or be limited. An emergency meeting of the CDC's outside advisory committee has been scheduled for Wednesday. "Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," said the statement. Regulators in Europe are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca PLC /zigman2/quotes/200304487/composite AZN +0.29% /zigman2/quotes/203048482/delayed UK:AZN +0.15% and Oxford University researchers. J&J shares slid 3.3% premarket, but are up 2.7% in the year to date through Monday, while the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.06% has gained 10.3%.

$ 170.22
+0.26 +0.15%
Volume: 5.80M
May 14, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$448.26 billion
Rev. per Employee
US : U.S.: Nasdaq
$ 55.21
+0.16 +0.29%
Volume: 5.20M
May 14, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$145.44 billion
Rev. per Employee
UK : U.K.: London
7,864.00 p
+12.00 +0.15%
Volume: 1.41M
May 14, 2021 4:35p
P/E Ratio
Dividend Yield
Market Cap
£103.24 billion
Rev. per Employee
US : Dow Jones Global
+360.68 +1.06%
Volume: 307.38M
May 14, 2021 5:02p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.